Finally, the follow-up duration was limited to approximately 2 years, and longer-term studies are needed to further characterize the relationship between weight change and CV outcomes during semaglutide therapy
doi: 10.3389/FMICB.2020.00417 96 KhorshidianN.KhanniriE.KoushkiM
Diet is a frequent and often fixable trigger for palpitations
It depends on your province and your diagnosis
Still, larger and longer studies are needed before the long-term safety picture is fully clear
- Predominant gastrointestinal symptoms included: - Nausea (36.9%) - Fatigue (16.7%) - Vomiting (16.3%) - Constipation (15.3%) - Diarrhea (12.6%) Notably, the study uncovered new side effects, such as reproductive symptoms (e.g., menstrual irregularities) and temperature-related complaints (e.g., chills and hot flushes)